PJSC Pharmaceutical Plant Egis (batch release)

Ukraine

All drugs from this manufacturer

  • KETILEPT® RETARD

    The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy for severe depressive episodes in patients with major depressive disorder.

    Dosage form: tablets, coated, extended-release

    Active substance Dosage
    quetiapine 50 mg

    ATC: N05AH04

  • The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as prevention of relapses), and as adjunctive therapy for severe depressive episodes.

    Dosage form: tablets, coated, extended-release

    Active substance Dosage
    quetiapine 150 mg

    ATC: N05AH04

  • The drug is used for the treatment of schizophrenia, bipolar disorder (manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy for severe depressive episodes in patients with major depressive disorder.

    Dosage form: tablets, coated, extended-release

    Active substance Dosage
    quetiapine 200 mg

    ATC: N05AH04

  • The drug is used for the treatment of schizophrenia, bipolar disorder (manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy in severe depressive episodes.

    Dosage form: tablets, coated, extended-release

    Active substance Dosage
    quetiapine 300 mg

    ATC: N05AH04

  • The drug is used for the treatment of schizophrenia, bipolar disorder (manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy for severe depressive episodes.

    Dosage form: tablets, coated, extended-release

    Active substance Dosage
    quetiapine 400 mg

    ATC: N05AH04